Two major owners of INC Research have announced that they are to sell off 4.5 million shares as they look to lower their financial interest in the CRO.

The global clinical trial management system market is set to reach $920 million by the start of the next decade, with this growth boosted by contract research…

India’s Piramal Enterprises’ U.S. subsidiary will buy out a 100% stake in CDMO Ash Stevens for a deal worth over $50 million.

The FDA is looking into the safety of one treatment from the FAAH inhibitor class after a patient died and 5 were severely injured after taking high doses of a…

Evotec has posted a 37% sales jump in the first half of 2016 with its income bumped up to €75.7 million ($84.1 million) as it reaps the benefits of its collabs…

Medpace has raised $161 million in its initial public offering, the top end of the CRO’s desired range, despite persistent headwinds for other sectors…

Increasingly acquisitive Charles River Laboratories has signed a new pact with the Milner Therapeutics Institute and Consortium that will see it become the…

Pittsburgh’s Velocity Fund Partners has picked up CRO IndiPharm for an undisclosed amount, renaming the Philadelphia firm InClinica.